Yes, methylprednisolone raises blood sugar. It does this through multiple metabolic pathways, and the effect is dose-dependent. Whether you’re taking a short course of oral tablets (a Medrol dose pack), getting a joint injection, or receiving intravenous doses in a hospital, your blood glucose will likely climb to some degree. The spike is temporary in most cases, but how high it goes and how long it lasts depends on the dose, the route, and whether you already have diabetes.
Why Corticosteroids Raise Blood Sugar
Methylprednisolone belongs to the corticosteroid family, and one of its core functions is to liberate energy substrates, including glucose. It does this in three simultaneous ways. First, it ramps up glucose production in the liver by activating enzymes that convert amino acids and other molecules into new glucose. Second, it reduces the ability of your muscles to absorb glucose from the bloodstream, essentially making your tissues less responsive to insulin. Third, it promotes the breakdown of protein in muscle and fat in adipose tissue, flooding the bloodstream with raw materials the liver converts into even more glucose.
The insulin resistance piece is particularly important. Methylprednisolone interferes with insulin signaling inside your cells, making the insulin your pancreas produces less effective at its job. Your body compensates by pumping out more insulin. In animal studies, insulin levels rose dramatically after a single injection and didn’t return to baseline for up to 72 hours. If your pancreas can keep up with the extra demand, your blood sugar may rise only modestly. If it can’t, the rise can be significant.
How Quickly It Happens
A morning dose of a corticosteroid like methylprednisolone typically produces a blood sugar peak in the early afternoon, roughly 4 to 6 hours later. This pattern matters if you’re monitoring at home: a fasting morning reading might look normal while your post-lunch glucose is substantially elevated. Checking only in the morning can miss the spike entirely.
For single injections (such as a joint or trigger finger injection), studies on patients with diabetes show blood glucose rises significantly within the first day. In one study where 10 mg of methylprednisolone was injected into trigger fingers, blood sugar was elevated for one day and returned to baseline by day two. A larger study using 20 to 120 mg injected into the hand and wrist found blood sugar stayed elevated for two days before normalizing on day three. The pattern is consistent: the higher the dose, the longer the spike may persist, but single injections resolve within a few days.
Dose Matters
The blood sugar response to methylprednisolone is dose-dependent. In controlled research, animals given a single injection saw plasma glucose rise from about 110 to 131 mg/dL at one dose level, while a higher dose produced a comparable glucose rise but a far larger insulin response, with insulin levels climbing nearly tenfold. During continuous infusions, the higher dose pushed glucose from 65 to 142 mg/dL compared to 120 mg/dL at the lower dose.
What this means practically: a six-day Medrol dose pack (which starts at 24 mg and tapers down) will have a milder effect than the high-dose intravenous pulses sometimes used for conditions like multiple sclerosis flares or severe allergic reactions. The longer you take it and the higher the dose, the more pronounced and sustained the glucose elevation.
If You Already Have Diabetes
People with type 2 diabetes are especially vulnerable because their insulin signaling is already impaired. Adding methylprednisolone on top of that can push blood sugar well above target ranges, sometimes requiring temporary changes to diabetes medication or the addition of insulin. If you’re on oral diabetes medications alone, they may not be enough to cover the steroid-induced spike.
The American Diabetes Association’s 2025 hospital care standards specifically address steroid-induced hyperglycemia as a distinct category. For intermediate-acting steroids taken once or twice daily, a particular type of insulin (NPH) is often timed to match the steroid’s glucose-raising peak. For longer-acting steroids or continuous use, long-acting basal insulin may be needed to cover fasting glucose levels as well.
If You Don’t Have Diabetes
Methylprednisolone can raise blood sugar even in people with no history of diabetes. Most healthy individuals have enough pancreatic reserve to compensate, meaning glucose rises modestly and returns to normal quickly. But for those with undiagnosed prediabetes, a family history of diabetes, or obesity, a course of steroids can unmask glucose problems that were previously invisible. This is sometimes called steroid-induced diabetes, and it can persist as long as the steroid is being taken.
Monitoring Your Blood Sugar
How closely you need to monitor depends on your risk profile. Clinical guidelines recommend the following general approach:
- Known diabetes, in hospital: Blood glucose checks four times daily.
- No diabetes history, starting steroids: At least one daily glucose check, timed for early afternoon (when the spike is most likely) rather than first thing in the morning.
- At home with diabetes: Twice-weekly monitoring at minimum, though more frequent checks are better during the steroid course.
- After discharge from the hospital on steroids: At least once-daily monitoring should continue.
If any reading exceeds roughly 200 mg/dL (11.1 mmol/L), guidelines recommend increasing monitoring to four times daily and adjusting treatment. The early afternoon check is the most diagnostically useful one because it catches the steroid’s peak glucose effect.
How Quickly Blood Sugar Normalizes
Once you stop taking methylprednisolone, blood sugar typically returns to your baseline within one to three days, depending on the dose and duration of treatment. For single injections, the research is reassuring: most patients see glucose normalize by day two or three. For longer courses, the timeline extends. The body needs to clear the drug and restore normal insulin sensitivity, which happens gradually.
If you were put on insulin or had your diabetes medications adjusted during a steroid course, those changes usually need to be reversed as the steroid is tapered or stopped. Continuing the same insulin dose after stopping the steroid can cause low blood sugar, which is its own risk. Keeping track of your glucose readings through the taper gives you and your care team the information needed to adjust medications safely.